Danske Bank’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1M Buy
152,022
+3,816
+3% +$793K 0.07% 217
2026
Q1
$31.3M Sell
148,206
-10,399
-7% -$2.24M 0.08% 219
2025
Q4
$32.6M Sell
158,605
-24,992
-14% -$4.7M 0.08% 209
2025
Q3
$28.8M Sell
183,597
-5,886
-3% -$909K 0.07% 230
2025
Q2
$31.8M Sell
189,483
-2,056
-1% -$305K 0.08% 205
2025
Q1
$26.4M Buy
191,539
+61,299
+47% +$7.81M 0.08% 206
2024
Q4
$15.4M Buy
130,240
+19,739
+18% +$2.3M 0.05% 330
2024
Q3
$12.2M Buy
110,501
+1,000
+0.9% +$105K 0.04% 352
2024
Q2
$10.8M Sell
109,501
-80,749
-42% -$8.23M 0.04% 357
2024
Q1
$21.3M Buy
+190,250
New +$20.5M 0.07% 259

Other funds holding CAH

Danske Bank's CAH Position: Q2 2026 in Review

Danske Bank increased its Cardinal Health (CAH) stake by 2.6% in Q2 2026, buying an estimated $793K and bringing the position to 152,022 shares worth $36.1M. The position accounts for 0.07% of the portfolio, ranked #217.

Danske Bank first reported a position in CAH in Q1 2024 and has held it in 10 quarters since. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Danske Bank held 152,022 shares of Cardinal Health worth $36.1M as of Q2 2026.
  • Danske Bank bought 3,816 Cardinal Health shares in Q2 2026, an estimated $793K.
  • Cardinal Health made up 0.07% of Danske Bank's portfolio in Q2 2026, its #217 holding.
  • Danske Bank first reported a position in Cardinal Health in Q1 2024 and has held it in 10 quarters since.
  • 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.